A task analysis of central line-associated bloodstream infection (CLABSI) surveillance in home infusion therapy.

Autor: Hannum SM; Department of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD., Oladapo-Shittu O; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Salinas AB; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Weems K; Department of Hospital Epidemiology and Infection Control, Johns Hopkins Hospital, Baltimore, MD., Marsteller J; Department of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore, MD., Gurses AP; Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore, MD., Cosgrove SE; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Hospital Epidemiology and Infection Control, Johns Hopkins Hospital, Baltimore, MD; Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD., Keller SC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: skeller9@jhmi.edu.
Jazyk: angličtina
Zdroj: American journal of infection control [Am J Infect Control] 2022 May; Vol. 50 (5), pp. 555-562. Date of Electronic Publication: 2022 Mar 24.
DOI: 10.1016/j.ajic.2022.01.008
Abstrakt: Background: Barriers for home infusion therapy central line associated bloodstream infection (CLABSI) surveillance have not been elucidated and are needed to identify how to support home infusion CLABSI surveillance. We aimed to (1) perform a goal-directed task analysis of home infusion CLABSI surveillance, and (2) describe barriers to, facilitators for, and suggested strategies for successful home infusion CLABSI surveillance.
Methods: We conducted semi-structured interviews with team members involved in CLABSI surveillance at 5 large home infusion agencies to explore work systems used by members of the agency for home infusion CLABSI surveillance. We analyzed the transcribed interviews qualitatively for themes.
Results: Twenty-one interviews revealed 8 steps for performing CLABSI surveillance in home infusion therapy. Major barriers identified included the need for training of the surveillance staff, lack of a standardized definition, inadequate information technology support, struggles communicating with hospitals, inadequate time, and insufficient clinician engagement and leadership support.
Discussion: Staff performing home infusion CLABSI surveillance need health system resources, particularly leadership and front-line engagement, access to data, information technology support, training, dedicated time, and reports to perform tasks.
Conclusions: Building home infusion CLABSI surveillance programs will require support from home infusion leadership.
(Copyright © 2022 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: